Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Cheng Chiang

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Human Pathology|October 5, 2014
Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterationsHsien-Neng Huang, Wen-Chih Huang, Ching-Hung Lin, et al.
Cancer Medicine|November 11, 2022
Outcome and prognostic factors of unexpected ovarian carcinomasChing-Yu Cheng, Heng-Cheng Hsu, Yi-Jou Tai, et al.
American Journal of Cancer Research|October 13, 2022
Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patientsYi-Jou Tai, Cheng-Miao Ou, Ying-Cheng Chiang, et al.
Journal of Gynecologic Oncology|December 16, 2020
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patientsHsiao Yun Lu, Yi Jou Tai, Yu Li Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2014
Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutationHsien-Neng Huang, Ying-Cheng Chiang, Wen-Fang Cheng, et al.
Journal of Ovarian Research|May 1, 2026
A potential mutation-defined POLE/MMR/TP53 group classifications to stratify BRCA wild type epithelial ovarian cancerYi-Ting Chen, Po-Han Lin, Yi-Jou Tai, et al.
International Journal of Environmental Research and Public Health|July 21, 2019
Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical CenterYi-Jou Tai, Heng-Cheng Hsu, Ying-Cheng Chiang, et al.
Scientific Reports|January 19, 2023
Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancersYi-Jou Tai, Chun-Ju Chiang, Ying-Cheng Chiang, et al.
Briefings in Bioinformatics|May 6, 2026
Development of a novel multimodal deep learning approach to improve diagnostic precision in ovarian cancerPo-Chun Chiu, Chia-Yi Lee, Heng-Cheng Hsu, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 21, 2017
Risk factors associated with failure of treatment for cesarean scar pregnancyYing-Cheng Chiang, Yi-An Tu, Jehn-Hsiahn Yang, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Human Pathology|October 5, 2014
Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterationsHsien-Neng Huang, Wen-Chih Huang, Ching-Hung Lin, et al.
Cancer Medicine|November 11, 2022
Outcome and prognostic factors of unexpected ovarian carcinomasChing-Yu Cheng, Heng-Cheng Hsu, Yi-Jou Tai, et al.
American Journal of Cancer Research|October 13, 2022
Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patientsYi-Jou Tai, Cheng-Miao Ou, Ying-Cheng Chiang, et al.
Journal of Gynecologic Oncology|December 16, 2020
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patientsHsiao Yun Lu, Yi Jou Tai, Yu Li Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2014
Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutationHsien-Neng Huang, Ying-Cheng Chiang, Wen-Fang Cheng, et al.
Journal of Ovarian Research|May 1, 2026
A potential mutation-defined POLE/MMR/TP53 group classifications to stratify BRCA wild type epithelial ovarian cancerYi-Ting Chen, Po-Han Lin, Yi-Jou Tai, et al.
International Journal of Environmental Research and Public Health|July 21, 2019
Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical CenterYi-Jou Tai, Heng-Cheng Hsu, Ying-Cheng Chiang, et al.
Scientific Reports|January 19, 2023
Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancersYi-Jou Tai, Chun-Ju Chiang, Ying-Cheng Chiang, et al.
Briefings in Bioinformatics|May 6, 2026
Development of a novel multimodal deep learning approach to improve diagnostic precision in ovarian cancerPo-Chun Chiu, Chia-Yi Lee, Heng-Cheng Hsu, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 21, 2017
Risk factors associated with failure of treatment for cesarean scar pregnancyYing-Cheng Chiang, Yi-An Tu, Jehn-Hsiahn Yang, et al.
Pageof 8